These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15370162)

  • 1. The relationship between smoking cessation and mouth ulcers.
    McRobbie H; Hajek P; Gillison F
    Nicotine Tob Res; 2004 Aug; 6(4):655-9. PubMed ID: 15370162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the reaction of abstaining smokers to the smell of other people's cigarettes predict relapse?
    McRobbie H; Hajek P; Locker J
    Addiction; 2008 Nov; 103(11):1883-7. PubMed ID: 19032537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
    Schneider MP; van Melle G; Uldry C; Huynh-Ba M; Fallab Stubi CL; Iorillo D; Burnier M; Zellweger JP
    Nicotine Tob Res; 2003 Oct; 5(5):719-27. PubMed ID: 14577988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
    McRobbie H; Hajek P
    Hum Psychopharmacol; 2004 Jan; 19(1):57-61. PubMed ID: 14716714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation.
    Staner L; Luthringer R; Dupont C; Aubin HJ; Lagrue G
    Sleep Med; 2006 Mar; 7(2):147-54. PubMed ID: 16458598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
    David SP; Niaura R; Papandonatos GD; Shadel WG; Burkholder GJ; Britt DM; Day A; Stumpff J; Hutchison K; Murphy M; Johnstone E; Griffiths SE; Walton RT
    Nicotine Tob Res; 2003 Dec; 5(6):935-42. PubMed ID: 14668077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupressure for smoking cessation--a pilot study.
    White AR; Moody RC; Campbell JL
    BMC Complement Altern Med; 2007 Mar; 7():8. PubMed ID: 17359519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for smoking cessation during pregnancy.
    Benowitz N; Dempsey D
    Nicotine Tob Res; 2004 Apr; 6 Suppl 2():S189-202. PubMed ID: 15203821
    [No Abstract]   [Full Text] [Related]  

  • 11. Postintervention effect of nicotine replacement therapy for smoking reduction: a randomized trial with a 5-year follow-up.
    Etter JF; Laszlo E
    J Clin Psychopharmacol; 2007 Apr; 27(2):151-5. PubMed ID: 17414237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia.
    Wardman AE; Khan N
    Nicotine Tob Res; 2004 Aug; 6(4):689-92. PubMed ID: 15370165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S; Ferguson SG; Strahs KR
    Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user.
    Hajek P; McRobbie H; Gillison F
    Prev Med; 2007 Mar; 44(3):230-4. PubMed ID: 17207524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization.
    Sundblad BM; Larsson K; Nathell L
    Nicotine Tob Res; 2008 May; 10(5):883-90. PubMed ID: 18569763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
    O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
    Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes.
    Meine TJ; Patel MR; Washam JB; Pappas PA; Jollis JG
    Am J Cardiol; 2005 Apr; 95(8):976-8. PubMed ID: 15820167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy and smoking cessation at a tobacco dependence clinic.
    Steinberg MB; Foulds J; Richardson DL; Burke MV; Shah P
    Prev Med; 2006 Feb; 42(2):114-9. PubMed ID: 16375954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing a hospital-based smoking cessation programme: evidence for a learning effect.
    Raupach T; Shahab L; Neubert K; Felten D; Hasenfuss G; Andreas S
    Patient Educ Couns; 2008 Feb; 70(2):199-204. PubMed ID: 18031972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.